ArticleSouth Asian journal of cancer2022
Serum Free Light Chain Assay as a Prognostic Marker in Patients with Aggressive B-Cell Non-Hodgkin's Lymphoma: Impact on Survival Outcome.
T M Anoop et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.